Evidence map›Paper›PMID 29662121›Full record

ReviewNature reviews. Immunology2018

Clocking in to immunity.

Christoph Scheiermann, Julie Gibbs, Louise Ince, Andrew Loudon

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 316 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
316citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

316 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Innate immunity: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  19. Review
  20. Review

256 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Christoph ScheiermannWalter Brendel Centre of Experimental Medicine, University Hospital, Ludwig-Maximilians-University Munich, Biomedical Centre, Planegg, Martinsried, Germany. christoph.scheiermann@med.uni-muenchen.de.
Julie GibbsSchool of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Louise InceWalter Brendel Centre of Experimental Medicine, University Hospital, Ludwig-Maximilians-University Munich, Biomedical Centre, Planegg, Martinsried, Germany.ORCID 0000-0002-2093-0876
Andrew LoudonSchool of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK. andrew.loudon@manchester.ac.uk.

Funding

Versus Arthritis 20629Wellcome Trust 107851/Z/15/Z
6 · The paper itself

Abstract

Circadian rhythms are a ubiquitous feature of virtually all living organisms, regulating a wide diversity of physiological systems. It has long been established that the circadian clockwork plays a key role in innate immune responses, and recent studies reveal that several aspects of adaptive immunity are also under circadian control. We discuss the latest insights into the genetic and biochemical mechanisms linking immunity to the core circadian clock of the cell and hypothesize as to why the immune system is so tightly controlled by circadian oscillations. Finally, we consider implications for human health, including vaccination strategies and the emerging field of chrono-immunotherapy.

Indexed as

Adaptive ImmunityAnimalsChronotherapyCircadian ClocksCircadian RhythmGastrointestinal MicrobiomeHost-Pathogen InteractionsHumansImmunity, InnateImmunotherapyLymphocytesModels, ImmunologicalSeasons

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.